In vitro development of haemopoietic progenitors in myelodysplastic syndromes (MDS) -: Response

被引：0
|
作者：
Brada, SJL
de Wolf, JTM
Hendriks, DW
Smit, JW
Vellenga, E
机构：
来源：
LEUKEMIA | 1999年 / 13卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：495 / 495
页数：1
相关论文
共 50 条
  • [31] RESPONSE TO RECOMBINANT-HUMAN-ERYTHROPOIETIN TREATMENT IN MYELODYSPLASTIC SYNDROMES (MDS)
    HAST, R
    CELSING, F
    EKMAN, M
    STENKE, L
    JOURNAL OF INTERNAL MEDICINE, 1991, 229 (04) : 381 - 382
  • [32] Pregnancy in patients with myelodysplastic syndromes (MDS)
    Volpicelli, P.
    Latagliata, R.
    Breccia, M.
    Carmosino, I.
    Stefanizzi, C.
    Napoleone, L.
    Vozella, F.
    Levi, A.
    Natalino, E.
    Alimena, G.
    LEUKEMIA RESEARCH, 2008, 32 (10) : 1605 - 1607
  • [33] Cytogenetic changes in myelodysplastic syndromes (MDS)
    Haus, O
    Kotlarek-Haus, S
    Czarnecka, M
    Potoczek, S
    Kyrcz-Krzemien, S
    Duszenko, E
    Makowska, I
    CYTOGENETICS AND CELL GENETICS, 1999, 85 (1-2): : 71 - 71
  • [34] Recent advances in myelodysplastic syndromes (MDS)
    Ascari, E
    HAEMATOLOGICA, 1998, 83 (03) : 287 - 288
  • [35] Mutational profile and haematological response to iron chelation in myelodysplastic syndromes (MDS)
    Fabiani, Emiliano
    Calabrese, Chiara
    Niscola, Pasquale
    Balleari, Enrico
    Molteni, Alfredo
    Finelli, Carlo
    Falconi, Giulia
    Fenu, Susanna
    Fianchi, Luana
    Criscuolo, Marianna
    Salvi, Flavia
    Lavorgna, Serena
    Buccisano, Francesco
    Maurillo, Luca
    Lo Coco, Francesco
    Cilloni, Daniela
    Voso, Maria Teresa
    BRITISH JOURNAL OF HAEMATOLOGY, 2019, 185 (05) : 954 - 957
  • [36] BIOLOGICAL FEATURES OF MYELODYSPLASTIC SYNDROMES (MDS) PREDICTS FOR SURVIVAL AND THERAPY RESPONSE
    BERAN, M
    KEATING, MJ
    MCCREDIE, KB
    MYELODYSPLASTIC SYNDROMES : PATHOPHYSIOLOGY AND TREATMENT, 1988, 783 : 155 - 170
  • [37] Oral prednisolone produces a durable response in pediatric myelodysplastic syndromes (MDS).
    Chandy, M
    George, B
    Mathews, V
    Viswabandya, A
    Bajel, A
    Srivastava, A
    BLOOD, 2005, 106 (11) : 306B - 306B
  • [38] Current State and Challenges in Development of Targeted Therapies in Myelodysplastic Syndromes (MDS)
    Stanchina, Michele
    Chaudhry, Sana
    Karr, Matthew
    Taylor, Justin
    HEMATO, 2021, 2 (02): : 217 - 236
  • [39] Development and Validation of a Model to Predict Response to Romiplostim in Patients with Lower-Risk Myelodysplastic Syndromes (MDS).
    Sekeres, Mikkael A.
    Giagounidis, Aristoteles
    Kantarjian, Hagop M.
    Mufti, Ghulam J.
    Fenaux, Pierre
    Jia, Catherine
    Yang, Allen S.
    Platzbecker, Uwe
    BLOOD, 2012, 120 (21)
  • [40] Iron overload in myelodysplastic syndromes (MDS) -: diagnosis, management, and response criteria:: a proposal of the Austrian MDS platform
    Valent, P.
    Krieger, O.
    Stauder, R.
    Wimazal, F.
    Noesslinger, T.
    Sperr, W. R.
    Sill, H.
    Bettelheim, P.
    Pfeilstoecker, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2008, 38 (03) : 143 - 149
12345